Showing results (171-180 of 208) with videos related to
Sort By:
Pageof 21
Magnetic Resonance in Medicine|September 1, 1994
Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosisJ F Hiehle, R E Lenkinski, R I Grossman, et al.Journal of Neurology|February 19, 2014
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosisT L Vollmer, P S Sorensen, K Selmaj, et al.Cancer Research|January 15, 1990
Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lungD B Weiner, J Nordberg, R Robinson, et al.Neurology|February 1, 1986
A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosisJ T Caroscio, J A Cohen, J Zawodniak, et al.Neurology|February 26, 2000
Intrarater and interrater reliability of the MS functional composite outcome measureJ A Cohen, J S Fischer, D M Bolibrush, et al.DNA and Cell Biology|July 1, 1993
Characterization of a mouse beta 1-adrenergic receptor genomic cloneJ A Cohen, L A Baggott, C Romano, et al.Neurology|August 2, 2008
Dose comparison trial of sustained-release fampridine in multiple sclerosisA D Goodman, T R Brown, J A Cohen, et al.Journal of Neurochemistry|February 4, 1999
Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteinsF P Zemlan, W S Rosenberg, P A Luebbe, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS)B O Khatri, J Pelletier, L Kappos, et al.Neurology|February 26, 2000
Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessmentY Ge, R I Grossman, J K Udupa, et al.Pageof 21